476 results match your criteria: "Centre d'Immunologie et des Maladies Infectieuses CIMI[Affiliation]"

Prevalence and severity of malnutrition in hospitalized COVID-19 patients.

Clin Nutr ESPEN

December 2020

Assistance Publique-Hôpitaux de Paris (AP-HP), Nutrition Department, Pitié-Salpêtrière University Hospital, Institute of Cardiometabolism and Nutrition (ICAN), Sorbonne Université, 47-83 Boulevard de l'Hôpital, 75013, Paris, France.

Article Synopsis
  • The study aims to evaluate malnutrition in hospitalized COVID-19 patients and its correlation with disease severity and clinical outcomes like ICU transfer or death.
  • Among 114 patients studied, a significant 42.1% were found to be malnourished, with an even higher rate of 66.7% in those coming from the ICU.
  • Lower levels of albumin were linked to an increased risk of ICU transfer, indicating a crucial need for early nutritional assessments in COVID-19 patients to improve management.
View Article and Find Full Text PDF

Background: Tertiary lymphoid structures (TLS) are triggered by persistent bronchopulmonary infection with , but their roles remain elusive. The present study sought to examine the effects of B- and/or T-cell depletion on infection and TLS development (lymphoid neogenesis) in mice.

Methods: C57Bl/6 mice were pre-treated with 1) an anti-CD20 monoclonal antibody (mAb) (B-cell depletion) or 2) an anti-CD4 and/or an anti-CD8 mAb (T-cell depletion) or 3) a combination of anti-CD20, anti-CD4 and anti-CD8 mAbs (combined B- and T-cell depletion) or 4) isotype control mAbs.

View Article and Find Full Text PDF

Hip fracture (HF) is common in the geriatric population and is associated with a poor vital and functional prognosis which could be impacted by immunological changes. The objective here is to decipher immune changes occurring in the 1st days following HF and determine how phenotype, function, and regulation of innate and adaptive compartments adapt during acute stress event. We included HF patients, aged over 75 years.

View Article and Find Full Text PDF
Article Synopsis
  • Anecdotal evidence in March 2020 indicated that sudden loss of smell (hyposmia) and taste (hypogeusia) were significant symptoms of COVID-19, prompting a study on their prevalence among various patient groups.
  • In a survey conducted in Paris, they found that 33% of all COVID-19 patients reported these symptoms, but they were less common in hospitalized patients compared to those seen in outpatient settings.
  • Younger patients with these symptoms tended to experience milder respiratory issues, suggesting that olfactory and gustatory dysfunction could help identify potential COVID-19 cases, especially among younger individuals.
View Article and Find Full Text PDF

Metabolic Optimisation of Regulatory T Cells in Transplantation.

Front Immunol

April 2021

Inserm U1135, Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris), Hôpital Pitié-Salpêtrière, AP-HP, Sorbonne Université, Paris, France.

Regulatory T (Treg) cells expressing the FOXP3 transcription factor are presently under investigation by many teams globally as a cellular therapy to induce tolerance in transplantation. This is primarily due to their immunosuppressive and homeostatic functions. Depending on the type of allograft, Treg cells will need to infiltrate and function in metabolically diverse microenvironments.

View Article and Find Full Text PDF

[Adaptive immunity against SARS-CoV-2].

Med Sci (Paris)

October 2020

Sorbonne Université, Inserm U1135, Centre d'Immunologie et des Maladies Infectieuses (Cimi-Paris), 91 boulevard de l'Hôpital, 75013 Paris, France.

The impact of host adaptive immune response on COVID-19 has now become a critical issue in absence of specific therapy and immunotherapies. In SARS CoV-2 infection, the immune response is thought to contribute both to the pathogenesis of the disease and to protection during its resolution. While mild cases develop an immune response that contributes to host protection, immunity of severely infected patients is a balance between harmful and protective immune responses.

View Article and Find Full Text PDF

When Therapeutic IgA Antibodies Might Come of Age.

Pharmacology

February 2021

Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris), Sorbonne Université, Inserm, AP-HP Hôpital Pitié-Salpêtrière, Paris, France,

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

View Article and Find Full Text PDF

Coronavirus Disease 2019 Acute Myocarditis and Multisystem Inflammatory Syndrome in Adult Intensive and Cardiac Care Units.

Chest

February 2021

Sorbonne Université, Institut de Cardiométabolisme et Nutrition (ICAN), Service de Médecine Intensive Réanimation, Hôpital La Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.

View Article and Find Full Text PDF

Response to: 'Implications of SARS-CoV-2 infection for patients with rheumatic disease' by Lin .

Ann Rheum Dis

August 2022

Sorbonne Université, Assistance Publique-Hôpitaux de Paris, Groupement Hospitalier Pitié-Salpêtrière, French National Referral Center for Systemic Lupus Erythematosus, Antiphospholipid Antibody Syndrome and Other Autoimmune Disorders, Service de Médecine Interne 2, Institut E3M, Inserm UMRS, Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris), Paris, France.

View Article and Find Full Text PDF

Response to 'Impact of COVID-19 pandemic on hospitalisation of patients with systemic lupus erythematosus (SLE): report from a tertiary hospital during the peak of the pandemic' by Chuah .

Ann Rheum Dis

August 2022

Sorbonne Université, Assistance Publique-Hôpitaux de Paris, Groupement Hospitalier Pitié-Salpêtrière, French National Referral Center for Systemic Lupus Erythematosus, Antiphospholipid Antibody Syndrome and Other Autoimmune Disorders, Service de Médecine Interne 2, Institut E3M, Inserm UMRS, Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris), Paris, France.

View Article and Find Full Text PDF

Buruli ulcer (BU), caused by Mycobacterium ulcerans, is currently treated with a daily combination of rifampin and either injectable streptomycin or oral clarithromycin. An intermittent oral regimen would facilitate treatment supervision. We first evaluated the bactericidal activity of newer antimicrobials against M.

View Article and Find Full Text PDF

Serine/threonine phosphatases are responsible for modulating the activities of the protein kinases implicated in the development of several pathologies. Here we identified by a PEP-scan approach a peptide of LRRK2, a Parkinson's disease associated protein, interacting with the phosphatase PP1. In order to study its biological activity, the peptide was fused via its N-terminal to an optimized cell penetrating peptide.

View Article and Find Full Text PDF

Response to: 'Exacerbation of immune thrombocytopenia triggered by COVID-19 in patients with systemic lupus erythematosus' by Kondo .

Ann Rheum Dis

May 2021

Sorbonne Université, Assistance Publique-Hôpitaux de Paris, Groupement Hospitalier Pitié-Salpêtrière, French National Referral Center for Systemic Lupus Erythematosus, Antiphospholipid Antibody Syndrome and Other Autoimmune Disorders, Service de Médecine Interne 2, Institut E3M, Inserm UMRS, Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris), Paris, France.

View Article and Find Full Text PDF

Response to: 'Presence of anti-phospholipid antibodies in COVID-19: a case series study' by Amezcua-Guerra .

Ann Rheum Dis

May 2021

Sorbonne Université, Assistance Publique-Hôpitaux de Paris, Groupement Hospitalier Pitié-Salpêtrière, French National Referral Center for Systemic Lupus Erythematosus, Antiphospholipid Antibody Syndrome and Other Autoimmune Disorders, Service de Médecine Interne 2, Institut E3M, Inserm UMRS, Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris), Paris, France.

View Article and Find Full Text PDF

New chimeric TLR7/NOD2 agonist is a potent adjuvant to induce mucosal immune responses.

EBioMedicine

August 2020

Groupe Immunité des Muqueuses et Agents Pathogènes, Institut National de la Santé et de la Recherche Médicale (INSERM), Centre d'Investigation Clinique en Vaccinologie 1408, Faculté de Médecine de Saint-Etienne, Saint-Etienne, France. Electronic address:

Background: PRR (Pattern Recognition Receptor) agonists have been widely tested as potent vaccine adjuvants. TLR7 (Toll-Like Receptor 7) and NOD2 (nucleotide-binding oligomerization domain 2) are key innate receptors widely expressed at mucosal levels.

Methods: Here, we evaluated the immunostimulatory properties of a novel hybrid chemical compound designed to stimulate both TLR7 and NOD2 receptors.

View Article and Find Full Text PDF

Response to: 'COVID-19 among Malaysian patients with systemic lupus erythematosus on hydroxychloroquine' by Teh .

Ann Rheum Dis

May 2021

Sorbonne Université, Assistance Publique-Hôpitaux de Paris, Groupement Hospitalier Pitié-Salpêtrière, French National Referral Center for Systemic Lupus Erythematosus, Antiphospholipid Antibody Syndrome and Other Autoimmune Disorders, Service de Médecine Interne 2, Institut E3M, Inserm UMRS, Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris), Paris, France.

View Article and Find Full Text PDF

Hormone receptor (HR) breast cancer (BC) causes most BC-related deaths, calling for improved therapeutic approaches. Despite expectations, immune checkpoint blockers (ICBs) are poorly active in patients with HR BC, in part reflecting the lack of preclinical models that recapitulate disease progression in immunocompetent hosts. We demonstrate that mammary tumors driven by medroxyprogesterone acetate (M) and 7,12-dimethylbenz[a]anthracene (D) recapitulate several key features of human luminal B HRHER2 BC, including limited immune infiltration and poor sensitivity to ICBs.

View Article and Find Full Text PDF

SARS-CoV-2 epidemics raises a considerable issue of public health at the planetary scale. There is a pressing urgency to find treatments based upon currently available scientific knowledge. Therefore, we tentatively propose a hypothesis which hopefully might ultimately help save lives.

View Article and Find Full Text PDF

An unprecedented outbreak of pneumonia caused by a novel coronavirus (CoV), subsequently termed COVID-19 by the World Health Organization, emerged in Wuhan City (China) in December 2019. Despite rigorous containment and quarantine efforts, the incidence of COVID-19 continues to expand, causing explosive outbreaks in more than 160 countries with waves of morbidity and fatality, leading to significant public health problems. In the past 20 years, two additional epidemics caused by CoVs have occurred: severe acute respiratory syndrome-CoV, which has caused a large-scale epidemic in China and 24 other countries; and respiratory syndrome-CoV of the Middle East in Saudi Arabia, which continues to cause sporadic cases.

View Article and Find Full Text PDF

Response to: 'Impact of COVID-19 pandemic on patients with SLE: results of a large multicentric survey from India' by Goyal .

Ann Rheum Dis

May 2021

Sorbonne Université, Assistance Publique-Hôpitaux de Paris, Groupement Hospitalier Pitié-Salpêtrière, French National Referral Center for Systemic Lupus Erythematosus, Antiphospholipid Antibody Syndrome and Other Autoimmune Disorders, Service de Médecine Interne 2, Institut E3M, Inserm UMRS, Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris), Paris, France.

View Article and Find Full Text PDF

Background: In addition to their multilineage potential, mesenchymal stem cells (MSCs) have a broad range of functions from tissue regeneration to immunomodulation. MSCs have the ability to modulate the immune response and change the progression of different inflammatory and autoimmune disorders. However, there are still many challenges to overcome before their widespread clinical administration including the mechanisms behind their immunoregulatory function.

View Article and Find Full Text PDF

Reducing lupus flares: should we be more careful about stopping glucocorticoids?

Expert Rev Clin Immunol

June 2020

Sorbonne Université, Assistance Publique-Hôpitaux de Paris, Groupement Hospitalier Pitié-Salpêtrière, French National Referral Center for Systemic Lupus Erythematosus, Antiphospholipid Antibody Syndrome and Other Autoimmune Disorders, Service de Médecine Interne 2, Institut E3M, Inserm UMRS, Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris), Paris, France.

View Article and Find Full Text PDF
Article Synopsis
  • * Researchers used specific mice and advanced imaging techniques to study the roles of resident and newly recruited macrophages after nerve injury.
  • * They discovered that recruited macrophages specialize in removing myelin, while resident macrophages help with the regrowth of axons, offering insights for potential treatments for neurodegenerative diseases.
View Article and Find Full Text PDF